Alkem Laboratories Ltd
ALKEMAlkem Laboratories Ltd
ALKEMPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
35.98 | 6.00 | 1.06% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.76 | 5.90 | 0.56% |
Forecast & Ratings
Detailed Forecastfrom 20 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 3,924.39 | 5,164.55 | 5,799.54 | 6,516.59 | 7,444.89 | 8,448.58 | 9,098.22 | 10,796.84 | 11,815.34 | 12,925.70 | ||||||||||
Raw Materials | 1,724.28 | 2,068.32 | 2,511.13 | 2,477.74 | 2,941.33 | 3,574.89 | 3,832.30 | 4,715.77 | 4,444.47 | 10,649.55 | ||||||||||
Power & Fuel Cost | 53.31 | 66.33 | 86.34 | 112.64 | 121.48 | 130.14 | 129.95 | 162.96 | 163.94 | |||||||||||
Employee Cost | 645.87 | 861.08 | 1,003.85 | 1,191.64 | 1,362.46 | 1,505.49 | 1,621.03 | 1,962.71 | 2,131.35 | |||||||||||
Selling & Administrative Expenses | 702.47 | 879.56 | 1,014.86 | 1,175.61 | 1,288.44 | 1,412.40 | 1,224.58 | 1,722.20 | 2,163.71 | |||||||||||
Operating & Other expenses | 195.59 | 196.30 | 72.40 | 434.62 | 528.71 | 248.05 | 114.76 | 32.59 | 1,189.32 | |||||||||||
EBITDA | 602.87 | 1,092.96 | 1,110.96 | 1,124.34 | 1,202.47 | 1,577.61 | 2,175.60 | 2,200.61 | 1,722.55 | 2,276.15 | ||||||||||
Depreciation/Amortization | 70.94 | 93.31 | 101.17 | 143.03 | 193.18 | 252.76 | 274.58 | 303.96 | 310.42 | 294.19 | ||||||||||
PBIT | 531.93 | 999.65 | 1,009.79 | 981.31 | 1,009.29 | 1,324.85 | 1,901.02 | 1,896.65 | 1,412.13 | 1,981.96 | ||||||||||
Interest & Other Items | 81.11 | 71.24 | 45.16 | 55.33 | 54.63 | 65.06 | 58.92 | 52.37 | 107.36 | 114.51 | ||||||||||
PBT | 450.82 | 928.41 | 964.63 | 925.98 | 954.66 | 1,259.79 | 1,842.10 | 1,844.28 | 1,304.77 | 1,867.45 | ||||||||||
Taxes & Other Items | 59.23 | 186.82 | 72.60 | 295.04 | 194.15 | 132.72 | 257.08 | 198.66 | 320.60 | 294.26 | ||||||||||
Net Income | 391.59 | 741.59 | 892.03 | 630.94 | 760.51 | 1,127.07 | 1,585.02 | 1,645.62 | 984.17 | 1,573.19 | ||||||||||
EPS | 32.75 | 62.02 | 74.61 | 52.77 | 63.61 | 94.26 | 132.57 | 137.63 | 82.31 | 131.58 | ||||||||||
DPS | 4.00 | 12.70 | 15.00 | 13.00 | 16.00 | 25.00 | 30.00 | 34.00 | 50.00 | 50.00 | ||||||||||
Payout ratio | 0.12 | 0.20 | 0.20 | 0.25 | 0.25 | 0.27 | 0.23 | 0.25 | 0.61 | 0.38 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Investor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Alkem Laboratories Ltd | 57.52 | 6.00 | 1.06% |
Sun Pharmaceutical Industries Ltd | 43.54 | 6.22 | 0.75% |
Cipla Ltd | 39.63 | 4.68 | 0.62% |
Dr Reddy's Laboratories Ltd | 22.35 | 4.33 | 0.66% |
Price Comparison
Compare ALKEM with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 2.45%
Shareholding Pattern
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Alkem Laboratories Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
DSP Midcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1415% | Percentage of the fund’s portfolio invested in the stock 4.05% | Change in the portfolio weight of the stock over the last 3 months -0.81% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/61 (-2) |
Axis Midcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.7024% | Percentage of the fund’s portfolio invested in the stock 1.57% | Change in the portfolio weight of the stock over the last 3 months 0.22% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/95 (+3) |
Nippon India GROWTH FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.6809% | Percentage of the fund’s portfolio invested in the stock 1.57% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/105 (-7) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Increasing Dividends
ALKEM has increased dividends consistently over the last 5 years
Dividend Yield
Current dividend yield is 1.06%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹10.56 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateFeb 16, 2024
Dividend/Share
₹35.00
Ex DateEx Date
Feb 16, 2024
Cash Dividend
Ex DateEx DateAug 10, 2023
Dividend/Share
₹10.00
Ex DateEx Date
Aug 10, 2023
Cash Dividend
Ex DateEx DateFeb 17, 2023
Dividend/Share
₹25.00
Ex DateEx Date
Feb 17, 2023
Cash Dividend
Ex DateEx DateFeb 17, 2023
Dividend/Share
₹15.00
Ex DateEx Date
Feb 17, 2023
Cash Dividend
Ex DateEx DateAug 8, 2022
Dividend/Share
₹4.00
Ex DateEx Date
Aug 8, 2022
News & Opinions
Trade setup for Wednesday: 15 things to know before opening bell
5 months ago•Moneycontrol
Trade setup for Tuesday: Top 15 things to know before the opening bell
7 months ago•Moneycontrol
Trade setup for Friday: Top 15 things to know before the opening bell
7 months ago•Moneycontrol
Alkem Labs Q1 Results Review - International Markets, Lower Raw Material Cost Drive Earnings: Motilal Oswal
8 months ago•Bloomberg Quint
Trade setup for Friday: Top 15 things to know before the opening bell
8 months ago•Moneycontrol
Alkem Laboratories forays into ophthalmology segment
9 months ago•Moneycontrol
Alkem Labs to grow chronic therapies, biosimilars to drive future growth: MD
10 months ago•Economic Times
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 12.64%, vs industry avg of 8.36%
Increasing Market Share
Over the last 5 years, market share increased from 3.21% to 3.62%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 9.3%, vs industry avg of 9.82%